13 amino acid synthetic peptide designed within the C terminal region of Human KLRA1
Our Abpromise guarantee covers the use of ab83946 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ICC/IF||Use a concentration of 20 µg/ml.|
|WB||Use a concentration of 1 - 2 µg/ml. Predicted molecular weight: 25 kDa.|
|ELISA||Use at an assay dependent concentration.|
|IHC-P||Use a concentration of 2.5 µg/ml.|
ab83946 has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"